Project

AMGEN202100057

Scheduled · 2022 until 2024

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Scheduled
Start Date
2022
End Date
2024
Financing
Industry
Study Design
Multicenter, cross-sectional to summarize the Lp(a) distribution in subjects with history of MI and/or PCI. Subjects are eligible if their Lp(a) value is known to be >= 90mg/dl, or is unknown. In that case Lp(a) will be determined.
Partner
Kardiologie und Endokrinologie, KSSG
Brief description/objective

A Multicenter, Cross-sectional Study to Characterize the Distribution of Lipoprotein(a) Levels Among Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD).

The purpose of the study is to characterize the distribution of Lp(a) levels among subjects with ASCVD.